Press releases | WebDisclosure

Basculer en Français

10443	Companies
219242	Keywords
148699	Articles
115971	Press releases

Home
Press releases

PRESS RELEASE

published on 04/01/2025 at 15:45, 1 year 1 month ago

Applied DNA Positions TR8 PGx Testing Service as Pre-Emptive Testing for Safety of Fluoropyrimidine-Based Cancer Therapeutics Following Publication of Food and Drug Administration Safety Announcement
Applied DNA Sciences announces repositioning of TR8™ PGx testing service to offer tailored subpanels targeting genetic variants correlated with DPD enzyme deficiencies in cancer patients, following recent FDA safety announcement

Genetic Testing Applied DNA Sciences Pharmacogenomics TR8 PGx FDA Safety Announcement
PRESS RELEASE

published on 04/01/2025 at 15:31, 1 year 1 month ago

Original-Research: Lisata Therapeutics Inc (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research updates Lisata Therapeutics Inc (ISIN: US1280583022) research with a Buy recommendation and USD 15.00 target price. Lisata's FY/24 results exceeded expectations, with promising developments in certepetide trials and AI collaboration

First Berlin Equity Research Buy Recommendation Research Update Certepetide Lisata Therapeutics Inc
PRESS RELEASE

published on 04/01/2025 at 15:18, 1 year 1 month ago

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
The Vanguard Group, Inc. discloses a 11.35% stake in American Axle & Manufacturing Holdings, Inc. as of 31 March 2025 in a Form 8.3 filing

Form 8.3 Relevant Securities Position Disclosure Vanguard Group American Axle
PRESS RELEASE

published on 04/01/2025 at 15:18, 1 year 1 month ago

Form 8.3 - The Vanguard Group, Inc.: Aviva plc
The Vanguard Group, Inc. discloses 5.11% stake in Aviva plc on 31 March 2025. Purchased 14,962 securities at 5.55 GBP per unit

The Vanguard Group Financial Disclosure Stake Disclosure Securities Purchase Aviva Plc
PRESS RELEASE

published on 04/01/2025 at 15:17, 1 year 1 month ago

Form 8.3 - The Vanguard Group, Inc.: Bakkavor Group plc
The Vanguard Group, Inc. discloses a 1.60% stake in Bakkavor Group plc as of 31 March 2025 through Form 8.3 filing

Form 8.3 The Vanguard Group Stake Disclosure Financial Holdings Bakkavor Group Plc
PRESS RELEASE

published on 04/01/2025 at 15:13, 1 year 1 month ago

SYNBIOTIC presents medical cannabis as a pastille for the German market for the first time
SYNBIOTIC SE presents medical cannabis pastilles on the German market for the first time, offering a new, personalized, and effective dosage form. Partnering with BOLDER Arzneimittel, this innovation sets new standards for cannabis therapy

Germany Medical Cannabis Product Launch SYNBIOTIC SE Pastilles
PRESS RELEASE

published on 04/01/2025 at 15:05, 1 year 1 month ago

Informations sur le nombre total d'actions et de droits de vote au 31.03.2025
Communiqué relatif au nombre d'actions et de droits de vote pour S.A. au capital social de 3.440.916 euros. Informations conformes aux règles de l'AMF

Droits De Vote Capital Social AMF Paris S.A.
PRESS RELEASE

published on 04/01/2025 at 15:01, 1 year 1 month ago

Shareholders approved all resolutions
Shareholders approved all resolutions at OC Oerlikon's 2025 Annual General Meeting of Shareholders including dividend payout & board elections

Shareholders Dividend AGM OC Oerlikon Resolutions
PRESS RELEASE

published on 04/01/2025 at 14:45, 1 year 1 month ago

DON'T NOD sort Koira, un jeu d'aventure du Studio Tolima
Découvrez le trailer de lancement du jeu d'aventure poétique Koira, par DON'T NOD et Studio Tolima, disponible sur Steam et PlayStation 5 avec une réduction de lancement de 10% sur Steam jusqu'au 14 avril

DON'T NOD Réduction Koira Jeu D'aventure Studio Tolima
PRESS RELEASE

published on 04/01/2025 at 14:32, 1 year 1 month ago

Amundi Physical Metals plc: UK Final Terms
Amundi Physical Metals plc issues 640,000 ETC Securities under its Secured Precious Metal Linked ETC Securities Programme. Details in Final Terms dated 31 March 2025

Precious Metals Amundi Physical Metals Plc ETC Securities Final Terms Secured Programme

Accesswire

Published on 05/23/2026 at 03:15, 14 hours 58 minutes ago

UraniumX Approved for Trading on the OTCQB Venture Market and Announces Board Change
Published on 05/23/2026 at 03:00, 15 hours 13 minutes ago

Battery X Metals Reports Up to ~84 km Estimated Driving Range Increase Across Multiple BYD Electric Vehicles Following Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Trials, Demonstrating Performance Improvement Across the World’s Larges
Published on 05/23/2026 at 02:25, 15 hours 48 minutes ago

Battery X Metals Announces up to $2 Million Private Placement Financing and Initiative to Strengthen Balance Sheet
Published on 05/23/2026 at 02:25, 15 hours 48 minutes ago

Bolt Metals Completes 402 line-km MobileMT Survey at Northwind Property, Quebec
Published on 05/23/2026 at 01:00, 17 hours 13 minutes ago

LIR Life Sciences Announces Initiation of Phase 1 Macromolecule-Enabled Transdermal Delivery Development with Neuland Laboratories

View all ACCESSWIRE

EQS Group

Published on 05/23/2026 at 16:30, 1 hour 42 minutes ago

HiFS 2026: Upgrading Four Major Digital Finance Solutions to Accelerate Financial Institutions Toward Agentic Banking
Published on 05/23/2026 at 15:57, 2 hours 15 minutes ago

EQS-Adhoc: Delivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
Published on 05/22/2026 at 22:05, 20 hours 7 minutes ago

Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH
Published on 05/22/2026 at 22:05, 20 hours 7 minutes ago

Abivax Presents Q1 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with UC
Published on 05/22/2026 at 19:51, 22 hours 21 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Redemption Prices

Les Echos

Published on 05/22/2026 at 19:35, 22 hours 38 minutes ago

PROJET D'EVOLUTION DE SA GOUVERNANCE ET LA NOMINATION D'UN PRESIDENT DU DIRECTOIRE PAR INTERIM
Published on 05/22/2026 at 18:05, 1 day ago

Déclaration hebdomadaire d'opérations effectuées du 18 au 22 mai 2026
Published on 05/22/2026 at 18:05, 1 day ago

Disclosure of transactions in own shares from May 18 to May 22, 2026
Published on 05/22/2026 at 12:52, 1 day 5 hours ago

Communiqué du Conseil d’administration – Assemblée Générale du 22 mai 2026
Published on 05/22/2026 at 12:52, 1 day 5 hours ago

Release from the Board of Directors - Shareholders’ Meeting of May 22, 2026

View all LES ECHOS COMFI WIRE